![](/img/cover-not-exists.png)
Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx
Henning Bier, Thomas Hoffmann, Ulrich Hauser, Michael Wink, Martin Öchler, Andreas Kovar, Matthias Müser, Reinald KnechtVolume:
47
Language:
english
Pages:
6
DOI:
10.1007/s002800000270
Date:
June, 2001
File:
PDF, 99 KB
english, 2001